Gelesis Holdings, Inc. (GLSHQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Sep 22, 2025
Gelesis Holdings Market Cap
Gelesis Holdings has a market cap or net worth of $7.33 thousand as of October 13, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
7.33K
Enterprise Value
n/a
Revenue
12.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 24, 2020, Gelesis Holdings's market cap has decreased from 339.83M to 7.33K, a decrease of -100.00%. That is a compound annual growth rate of -87.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2025 | 7.33K | - |
| Dec 30, 2024 | 7.33K | -93.33% |
| Dec 29, 2023 | 110.00K | -99.48% |
| Dec 30, 2022 | 21.21M | -93.83% |
| Dec 31, 2021 | 343.62M | -1.87% |
| Dec 31, 2020 | 350.18M | 3.05% |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |